Neuroprotective effects of metabotropic glutamate receptor ligands in a rodent 6-hydroxydopamine model of Parkinson's disease

Neuroprotective effects of metabotropic glutamate receptor ligands in a rodent 6-hydroxydopamine model of Parkinson's disease

Bibliographic Details
Main Author:	Vernon, Anthony Christopher
Published:	Imperial College London 2007
Subjects:	616.833061
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.434780

Similar Items

Group III metabotropic glutamate receptors as potential targets in the treatment of Parkinson's disease
by: Broadstock, Martin
Published: (2006)

A behavioural and biochemical evaluation of the momoamine uptake inhibitor BTS 73 398 in the 6-hydroxydopamine lesioned rat model of Parkinson's disease
by: Lane, Emma Louise
Published: (2004)

The neuronal nicotinic acetylcholine receptor as a potential symptomatic and neuroprotective target in Parkinson's disease
by: Visanji, Naomi
Published: (2004)

Nicotinamide : neuroprotection and neurodegeneration mechanisms in Parkinson's disease
by: Cartwright, Lindsay Sarah
Published: (2005)

The role of group II and III metabotropc glutamate receptors in the basal ganglia and their potential as a treatment target for Parkinson's disease
by: Messenger, Marcus John
Published: (2003)

An evaluation of the potentially neuroprotective properties of cannabinoids in a cell culture model of Parkinson's disease
by: Zeissler, Marie-Louise
Published: (2013)

In vitro and in vivo investigations of the potential neuroprotective effects of propargylamines and dopamine receptor agonists
by: Wakselman, Shirley
Published: (2007)

The role of neopterin derivatives in the pathogenesis and treatment of Parkinson's disease
by: Noble, Stephen Paul
Published: (2002)

A behavioural and biochemical evaluation of Î±â‚‚-adrenoceptor antagonist fipamezole in experimental models of Parkinson's disease
by: Croft, Neil Ramsay
Published: (2006)

Parkinson's disease : behavioural effects following extracellular deposition of non-beta amyloid component and pharmacological interventions
by: Elliott, Jennifer Jane
Published: (2004)

Striatal and extra-striatal dopaminergic function in Parkinson's disease and the effect of dopamine agonist therapy on PD progression studies with 3D[Â¹â¸F]-dopa PET
by: Rakshi, James
Published: (2003)

An investigation of the potential antiparkinsonian activity of combined dopamine D2 and serotonin 1A receptor agonists
by: Johnston, Louisa Clare
Published: (2004)

Parkin protects against pathogenic mechanisms involved in cell death
by: Dowman, Julia Rebecca Louise
Published: (2005)

The neuroprotective and behavioural effects of group III metabotropic glutamate receptor ligands in rodent models of Parkinson's disease
by: Williams, Claire
Published: (2015)

Behavioural analysis of 6-hydroxydopamine rodent models of Parkinson's disease
by: Heuer, Andreas
Published: (2012)

Neuroprotective effects and mechanisms of the activation of group III metabotropic glutamate receptor in rodent models of Parkinson's disease
by: Chan, Hugh Hiu-Nam
Published: (2010)

Purine Nucleoside Mediated Neuroprotection in the 6-Hydroxydopamine Rodent Model of Parkinson's Disease
by: Terpstra, Brian T.
Published: (2011)

The Role of Metabotropic Glutamate Receptors in Social Behavior in Rodents
by: Iulia Zoicas, et al.
Published: (2019-03-01)

Investigating group III metabotropic glutamate receptors as novel therapeutic targets in Parkinson's disease and Levodopa-induced dyskinesia
by: Finlay, Clare Judith
Published: (2014)

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
by: Fabrizio Gasparini, et al.
Published: (2013-01-01)

Therapeutic potential of targeting group III metabotropic glutamate receptors as a disease modifying strategy in the treatment of Parkinson's disease
by: Betts, Matt
Published: (2012)

Role of inflammation in 6-hydroxydopamine model of Parkinson's disease and its modulation by Peroxisome Proliferator Activated Receptor gamma (PPAR-γ) agonist as a neuroprotective strategy
by: Sadeghian, Mona
Published: (2008)

Anticonvulsant effects of metabotropic glutamate receptors in a rodent model of epilepsy
by: Yip, Ping Kei
Published: (2001)

Elucidating the role of microglial group III metabotropic glutamate receptors in microglial inflammation : focus on Parkinson's disease and neuroprotection
by: Gonzalez Carter, Daniel Angel
Published: (2013)

Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection?
by: Simona Federica Spampinato, et al.
Published: (2018-11-01)

The targeting of metabotropic glutamate receptors
by: Yee Chan, Wai
Published: (2002)

Investigating the behavioural and molecular consequences of the loss of metabotropic glutamate receptor 2 in a Han Wistar rat strain
by: Wood, Christian Michael
Published: (2015)

PAIN IN A PARKINSON`S DISEASE RODENT ANIMAL MODEL INDUCED WITH 6-HYDROXYDOPAMINE
by: Antioch, I, et al.
Published: (2017-06-01)

Peripheral inflammation and neuroprotection: Systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease
by: Marie-Thérèse Armentero, et al.
Published: (2006-12-01)

Design and synthesis of ligands acting selectively at group III metabotropic glutamate receptors
by: Conway, Stuart John
Published: (2001)

Metabotropic Glutamate Receptors Inhibit Microglial Glutamate Release
by: Stephen M McMullan, et al.
Published: (2012-07-01)

Study of alternative splicing as a mechanism by which genetic variation in metabotropic glutamate receptor 3 contributes to risk for schizophrenia
by: Sartorius, Leah
Published: (2007)

G Protein Coupling and Regulation of Metabotropic Glutamate Receptor 6
by: Tian, Liantian
Published: (2010)

Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease.
by: Emma Thornton, et al.
Published: (2012-01-01)

Role of Metabotropic Glutamate Receptors in Neurological Disorders
by: Rosalia Crupi, et al.
Published: (2019-02-01)

Therapeutic Promise and Principles: Metabotropic Glutamate Receptors
by: Kenneth Maiese, et al.
Published: (2008-01-01)

Homology modelling of metabotropic glutamate receptor 2
by: Mordalski S, et al.
Published: (2011-04-01)

Scaffolding group II metabotropic glutamate receptors
by: Pilkington, Benjamin John
Published: (2004)

Contribution of metabotropic glutamate receptors to opioid dependence
by: Fundytus, Marian Elaine.
Published: (1996)

Contributions of metabotropic glutamate receptors to the pathophysiology of autism
by: Auerbach, Benjamin D. (Benjamin David)
Published: (2013)